{"date":"2025-03-21","count":26,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6919-2025-03-21-1946-zks4y0","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-03-21","time":"19:46:53","subject":"公告本公司董事會決議召開114年股東常會相關事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-03-21 19:46，「公告本公司董事會決議召開114年股東常會相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-03-21-1929-10sn9vw","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-03-21","time":"19:29:15","subject":"公告本公司董事會決議發行114年度限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-03-21 19:29，「公告本公司董事會決議發行114年度限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-03-21-1915-1k4l4c4","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-03-21","time":"19:15:10","subject":"公告本公司董事會決議修訂113年度限制員工權利新股發行辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-03-21 19:15，「公告本公司董事會決議修訂113年度限制員工權利新股發行辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-03-21-1834-1ev1paf","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-03-21","time":"18:34:40","subject":"本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-03-21 18:34，「本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-03-21-1833-xq8mzd","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-03-21","time":"18:33:46","subject":"公告本公司財務主管暨代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-03-21 18:33，「公告本公司財務主管暨代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-03-21-1756-1hv4kpd","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-03-21","time":"17:56:26","subject":"本公司董事會通過不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-03-21 17:56，「本公司董事會通過不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-03-21-1751-1cj873f","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-03-21","time":"17:51:52","subject":"董事會通過財務主管、會計主管及公司治理主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-03-21 17:51，「董事會通過財務主管、會計主管及公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-03-21-1751-1hw5atl","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-03-21","time":"17:51:29","subject":"本公司董事會通過召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-03-21 17:51，「本公司董事會通過召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-03-21-1750-sgbyf3","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-03-21","time":"17:50:37","subject":"本公司董事會通過113年合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-03-21 17:50，「本公司董事會通過113年合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-03-21-1750-1hkzzd6","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-03-21","time":"17:50:18","subject":"本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-03-21 17:50，「本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2025-03-21-1743-92x690","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"17:43:13","subject":"董事會決議股利分派","clause":"第31款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2025-03-21 17:43，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2025-03-21-1733-drgvb6","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"17:33:10","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2025-03-21 17:33，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2025-03-21-1732-v60i3u","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"17:32:12","subject":"公告本公司財務報告經董事會決議","clause":"第43款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2025-03-21 17:32，「公告本公司財務報告經董事會決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2025-03-21-1730-1x9xanp","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"17:30:19","subject":"公告本公司董事會決議召開股東會相關事宜","clause":"第32款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2025-03-21 17:30，「公告本公司董事會決議召開股東會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-03-21-1713-1bkm0mx","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-03-21","time":"17:13:29","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-03-21 17:13，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-03-21-1709-92x690","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"17:09:53","subject":"董事會決議股利分派","clause":"第31款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-03-21 17:09，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-03-21-1702-1dmdgdo","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"17:02:04","subject":"公告本公司董事會通過113年度財務報告","clause":"第43款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-03-21 17:02，「公告本公司董事會通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-03-21-1700-1pb8ufa","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"17:00:41","subject":"公告本公司董事會決議召開114年股東常會","clause":"第32款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-03-21 17:00，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2025-03-21-1606-1b2zikq","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"16:06:10","subject":"本公司財務主管、會計主管、及代理發言人異動","clause":"第11款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2025-03-21 16:06，「本公司財務主管、會計主管、及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2025-03-21-1556-1r616br","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"15:56:41","subject":"本公司董事會決議召開114年股東常會事宜","clause":"第32款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2025-03-21 15:56，「本公司董事會決議召開114年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2025-03-21-1554-rtz0tm","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"15:54:22","subject":"公告本公司董事會通過不分派113年度員工酬勞及董事酬勞","clause":"第44款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2025-03-21 15:54，「公告本公司董事會通過不分派113年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2025-03-21-1551-bwopfv","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"15:51:07","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2025-03-21 15:51，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2025-03-21-1531-1jj92yb","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2025-03-21","time":"15:31:56","subject":"公告本公司董事會通過113年度財報","clause":"第43款","fact_date":"2025-03-21","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2025-03-21 15:31，「公告本公司董事會通過113年度財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-03-21-1405-10yb8rh","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-03-21","time":"14:05:20","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-03-21 14:05，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-03-21-1337-350h2q","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-03-21","time":"13:37:31","subject":"本公司受邀參加富邦證券舉辦之法⼈說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-03-21 13:37，「本公司受邀參加富邦證券舉辦之法⼈說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-03-21-1251-kgzwup","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-03-21","time":"12:51:06","subject":"公告本公司將於114年03月27日舉辦上市前業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-03-21 12:51，「公告本公司將於114年03月27日舉辦上市前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}